Terms: = Brain cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Prognosis
7 results:
1. CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance.
Ma K; Chen S; Chen X; Zhao X; Yang J
J Mol Neurosci; 2022 Oct; 72(10):2106-2124. PubMed ID: 36006582
[TBL] [Abstract] [Full Text] [Related]
2. S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas.
Ma K; Chen S; Chen X; Yang C; Yang J
World Neurosurg; 2022 Sep; 165():e650-e663. PubMed ID: 35779750
[TBL] [Abstract] [Full Text] [Related]
3. CTSB is a negative prognostic biomarker and therapeutic target associated with immune cells infiltration and immunosuppression in gliomas.
Ma K; Chen X; Liu W; Chen S; Yang C; Yang J
Sci Rep; 2022 Mar; 12(1):4295. PubMed ID: 35277559
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human cancer.
Zheng M; Li YM; Liu ZY; Zhang X; Zhou Y; Jiang JL; Zhu P; Yang XM; Tang J; Chen ZN
Front Immunol; 2021; 12():731329. PubMed ID: 35069521
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract] [Full Text] [Related]
6. Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Wang J; Xu S; Lv W; Shi F; Mei S; Shan A; Xu J; Yang Y
Cancer Med; 2020 Aug; 9(16):5940-5947. PubMed ID: 32583596
[TBL] [Abstract] [Full Text] [Related]
7. Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma.
Liu F; Huang J; Xiong Y; Li S; Liu Z
Aging (Albany NY); 2019 Aug; 11(15):5463-5482. PubMed ID: 31377744
[TBL] [Abstract] [Full Text] [Related]
